Mumbai, June 13 -- The company emerged as the successful bidder through a competitive bidding process and received the letter of award (LoA) on 11 June 2025. The project, to be developed at a tariff ... Read More
Mumbai, June 13 -- Torrent Green Energy, wholly owned subsidiary of Torrent Power, has received two Letters of Award from Solar Energy Corporation of India (SECI) on 11 June 2025 for setting up of 300... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018401) titled 'Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitu... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017101) titled 'Effect of Neurophysiological Facilitation Techniques Applied in Addition to Pilates-based E... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018544) titled 'A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Survei... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018466) titled 'Tele-Exercise for MERP' on June 04. Brief Summary: During Operations Desert Shield and Des... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017166) titled 'Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018180) titled 'Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for ... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017231) titled 'Role of Interleukin-13 Pathways on Pain and Itch Sensitivity ( IL-13 )' on May 30. Brief S... Read More
U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017673) titled 'Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With ... Read More